News
LAUSANNE, Switzerland--(BUSINESS WIRE)--Alithea Genomics, a leader in the field of large-scale RNA sequencing and transcriptomics, announced today the launch of MERCURIUS™ Full-Length DRUG-seq ...
Alithea Genomics closed a CHF 2.8 million ($3.2 million) seed extension led by the Novalis Biotech Acceleration fund and included TechU Ventures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback